Status:
NOT_YET_RECRUITING
Artificial Intelligence Self Harm Application
Lead Sponsor:
Pakistan Institute of Living and Learning
Conditions:
Self-harm
Suicide
Eligibility:
All Genders
16-25 years
Phase:
NA
Brief Summary
This is a mixed-methods study. The quantitative component will comprise of a multicentre rater-blind, randomized controlled trial to evaluate the feasibility and acceptability of AISHA in addition to ...
Detailed Description
Mental health resources in LMICs, including Pakistan, do not match the burden of mental illness, resulting in a massive mental health treatment gap. Interventions delivered on mobile platforms (M-Heal...
Eligibility Criteria
Inclusion
- All patients presented to the participating family physicians, community health centres, emergency departments or admitted to a general hospital after an episode of self-harm at participating sites.
- Age 16 to 25 years
- Participants must be familiar with functioning of handheld mobile devices (mobile phones, tablets).
- Able to read Urdu or English language.
- Individuals able to provide written informed consent.
- Have an android mobile phone/device
Exclusion
- Participants with ICD-I0 mental disorder; due to a general medical condition or substance misuse, dementia, delirium, alcohol or drug dependence, schizophrenia, bipolar disorder, learning disability which prevents participation.
- Participants needing inpatient psychiatric treatment as determined by their clinical teams
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
312 Patients enrolled
Trial Details
Trial ID
NCT06019663
Start Date
June 1 2024
End Date
December 30 2025
Last Update
March 5 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Benazir Bhutto Hospital
Rawalpindi, Punjab Province, Pakistan, 203393
2
Civil Hospital
Karachi, Sindh, Pakistan, 203393